Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients with KRAS G12C-mutated non-small cell lung cancer.
Adagrasib shows promise for the treatment of patients with KRAS G12C-mutated non-small cell lung cancer
- Thread starter Educator
- Start date